Inventor · disambiguated record
Jonathan R. Lai
Also filed as: LAI JONATHAN · LAI JONATHAN R
20 granted patents·10 pending applications·41 citations·filing 2003–2023
91Inventor score
Files withALBERT EINSTEIN COLLEGE MEDICINE19ALBERT EINSTEIN COLLEGE MEDICINE INC4GENETIC INTELLIGENCE INC2LAI JONATHAN R2EINSTEIN COLL MED1
Top patents by PatentIndex Score
30 records- 0189US9346875B2Therapy for filovirus infectionEINSTEIN COLL MED·Filed 2014·Granted May 24, 2016·9 cites·8 claims
- 0285US10875907B2Filovirus antibodyALBERT EINSTEIN COLLEGE MEDICINE INC·Filed 2018·Granted Dec 29, 2020·3 cites·15 claims
- 0385US6958384B2Polypeptides containing γ-amino acidsWISCONSIN ALUMNI RES FOUND·Filed 2003·Granted Oct 25, 2005·22 cites·26 claims
- 0482US10391171B2Multi-specific antibodies for cross-neutralization of multiple filovirus glycoproteinsALBERT EINSTEIN COLLEGE MEDICINE·Filed 2017·Granted Aug 27, 2019·2 cites·15 claims
- 0581US11135292B2Multi-specific antibodies for cross-neutralization of multiple filovirus glycoproteinsALBERT EINSTEIN COLLEGE MEDICINE·Filed 2019·Granted Oct 5, 2021·1 cites·13 claims
- 0681US10377815B2Bispecific antibodies and fusion proteins that bind to EBOV and NPC1ALBERT EINSTEIN COLLEGE MEDICINE·Filed 2016·Granted Aug 13, 2019·2 cites·9 claims
- 0780US10081669B2Therapy for filovirus infectionALBERT EINSTEIN COLLEGE MEDICINE INC·Filed 2016·Granted Sep 25, 2018·2 cites·9 claims
- 0873US12202888B2High-affinity Mycobacterium tuberculosis capsule-specific human monoclonal antibodyALBERT EINSTEIN COLLEGE MEDICINE·Filed 2023·Granted Jan 21, 2025·0 cites·19 claims
- 0971US12162926B2Multi-specific antibodies for cross-neutralization of multiple filovirus glycoproteinsALBERT EINSTEIN COLLEGE MEDICINE·Filed 2021·Granted Dec 10, 2024·0 cites·19 claims
- 1071US11174308B2Synthetic antibodies to BAX and uses thereofALBERT EINSTEIN COLLEGE MEDICINE·Filed 2020·Granted Nov 16, 2021·0 cites·9 claims
- 1170US10759851B2Synthetic antibodies to BAX and uses thereofALBERT EINSTEIN COLLEGE MEDICINE·Filed 2019·Granted Sep 1, 2020·0 cites·9 claims
- 1268US11905322B2Engineered PD-1 variantsALBERT EINSTEIN COLLEGE MEDICINE·Filed 2021·Granted Feb 20, 2024·0 cites·19 claims
- 1367US11643455B2High-affinity Mycobacterium tuberculosis capsule-specific human monoclonal antibodyALBERT EINSTEIN COLLEGE MEDICINE·Filed 2020·Granted May 9, 2023·0 cites·8 claims
- 1467US11149080B2Methods of treating filovirus infections utilizing bispecific antibodies and fusion proteins that bind EBOV and NPC1ALBERT EINSTEIN COLLEGE MEDICINE·Filed 2019·Granted Oct 19, 2021·0 cites·18 claims
- 1563US10294294B2Synthetic antibodies to BAX and uses thereofALBERT EINSTEIN COLLEGE MEDICINE INC·Filed 2016·Granted May 21, 2019·0 cites·9 claims
- 1660US2024352094A1Compositions and methods for the treatment of herpes simplex virus infectionALBERT EINSTEIN COLLEGE MEDICINE·Filed 2022·Application pending·0 cites
- 1760US2021292394A1Filovirus antibodyALBERT EINSTEIN COLLEGE MEDICINE·Filed 2020·Application pending·0 cites
- 1858US11352413B2Engineered PD-1 variantsALBERT EINSTEIN COLLEGE MEDICINE·Filed 2017·Granted Jun 7, 2022·0 cites·27 claims
- 1958US2023000979A1Anti-crimean-congo hemorrhagic fever virus antibodies, and methods of their generation and useALBERT EINSTEIN COLLEGE MEDICINE·Filed 2022·Application pending·0 cites
- 2055US2021355195A1Anti-crimean-congo hemorrhagic fever virus antibodies, and methods of their generation and useALBERT EINSTEIN COLLEGE MEDICINE·Filed 2021·Application pending·0 cites
- 2150US2023167447A1Compositions for FNIP1/FNIP2 Gene Modulation and Methods ThereofGENETIC INTELLIGENCE INC·Filed 2022·Application pending·0 cites
- 2249US2025368623A1Pyridazinone-derived compounds for the modulation of myc and for medical usesGENETIC INTELLIGENCE INC·Filed 2023·Application pending·0 cites
- 2348US2025320277A1Antibodies or antibody-fragments thereof targeting alphaviruses, and compositions and methods comprising sameALBERT EINSTEIN COLLEGE MEDICINE·Filed 2021·Application pending·0 cites
- 2447US12186383B2Antibodies or antibody-fragments thereof targeting alphaviruses, and compositions and methods comprising sameALBERT EINSTEIN COLLEGE MEDICINE·Filed 2019·Granted Jan 7, 2025·0 cites·26 claims
- 2545US10772949B2Dengue virus glycoprotein E DIII variants and uses thereofALBERT EINSTEIN COLLEGE MEDICINE·Filed 2017·Granted Sep 15, 2020·0 cites·21 claims
- 2644US2021163578A1High-affinity mycobacterium tuberculosis capsule-specific human monoclonal antibodyALBERT EINSTEIN COLLEGE MEDICINE·Filed 2019·Application pending·0 cites
- 2743US2010048422A1Methods of Producing Modified Assembly Lines and Related CompositionsWALSH CHRISTOPHER T·Filed 2006·Application pending·0 cites
- 2839US10435461B2Therapy for filovirus infectionALBERT EINSTEIN COLLEGE MEDICINE INC·Filed 2015·Granted Oct 8, 2019·0 cites·15 claims
- 2937US2022372079A1Resurfaced dengue virus and ziki virus glycoprotein e diii variants and uses thereofLAI JONATHAN R·Filed 2020·Application pending·0 cites
- 3035US9360483B2Constructs and methods to identify antibodies that target glycansLAI JONATHAN R·Filed 2011·Granted Jun 7, 2016·0 cites·12 claims
Join the waitlist — get patent alerts
Get an alert when Jonathan R. Lai files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →